Other Clinical Trial - InPen User Experience

Status Completed

Clinical Trial Summary

The purpose of this study is to evaluate the user experience of InPen™ with InPen™ Diabetes Management App and Guardian 4 system in adult patients with type 1 diabetes for the design of a future pivotal study.

Clinical Trial Description

This study is a multi-center, single arm study in insulin-requiring adult subjects with type 1 diabetes treated with MDI (basal and bolus) therapy. The total study duration will be approximately 10 weeks long for each participant. The study consists of a run-in (phase 1) and study phases 2, 3 and 4. Phase 1: The purpose of the run-in phase is to collect baseline HbA1c and blinded Continuous Glucose Monitoring (CGM) data while subjects are on their current MDI therapy. Phase 2: All subjects will utilize a smart bolus insulin pen injector (InPen™) and app with dose calculator (InPen™ Diabetes Management App), and will continue their own SMBG, iscCGM or RT-CGM for two weeks. Phase 3: Subjects will continue on the InPen and InPen App for another two weeks utilizing the HCP insights gained during the titration follow-up visit. Phase 4: All subjects will utilize the InPen™ system consisting of: - InPen™ and InPen™ Diabetes Management App - Guardian™ 4 system (RT-CGM) - Guardian™ 4 sensor - Guardian™ 4 transmitter - Guardian™ 4 app ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05029271
Study type	Interventional
Source	Medtronic Diabetes
Contact
Status	Completed
Phase	N/A
Start date	April 17, 2023
Completion date	December 8, 2023

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT02546401` - Comparison of Insulin's Injection Before or After the Meal in Type 1 Diabetic Patients Treated With Insulin Pump	Phase 3
Enrolling by invitation	`NCT06207838` - Transition of T1DM Patients Aged Over 65 Years Into AHCL (780G) Insulin Pump	N/A
Withdrawn	`NCT02057497` - An Exploratory Clinical Trial to Generate Whole Blood Samples for Analysing Genetic Polymorphisms	N/A
Active, not recruiting	`NCT05088616` - Native American Diabetes Project	N/A
Withdrawn	`NCT01501032` - Inpatient Evaluation of the MD-Logic Artificial Pancreas System in Patients With Type 1 Diabetes	Phase 1
Completed	`NCT01770561` - Feasibility Study of an Integrated Sensor and Infusion Set	N/A
Completed	`NCT00417131` - Imaging of Islet Transplantation With PET and MRT	N/A
Completed	`NCT03538106` - Factors Associated With Cesarean Delivery in Women With Type 1 Diabetes
Completed	`NCT01565824` - Web-based Support During Pregnancy and Early Motherhood in Women With Type 1 Diabetes (MODIAB-web)	N/A
Recruiting	`NCT04257877` - Proteomic Analysis in Paediatric Diabetes Type 1 (PAPD)
Withdrawn	`NCT01322321` - ACZ885 in Type 1 Diabetes Mellitus	Phase 2
Active, not recruiting	`NCT04794283` - Antenatal Hand Milking for Pregnant Women With Diabetes'
Completed	`NCT03842683` - CGM Precision and Glycaemic Variability
Suspended	`NCT04874532` - A Study to Improve Diabetes Management Among Adults Experiencing Severe Hypoglycemia	N/A
Terminated	`NCT00925977` - Treatment Satisfaction of Insulin Glargine Plus Insulin Apidra Compared With NPH Insulin Plus Insulin Apidra in Recently Diagnosed Type 1 Diabetes Children and Adolescents	N/A
Completed	`NCT02066350` - Cardiovascular Risk Factors After Single Pancreas Transplantation	N/A
Completed	`NCT02137174` - Home and School Visits Intervention for Children With DM TYPE 1	Phase 2/Phase 3
Completed	`NCT06365255` - National Epidemiological Study of the Possible Impact of Stress on Glycaemic Control in Patients With Type 1 Diabetes
Completed	`NCT03433677` - A Study of LY900014 and Insulin Lispro With an External Continuous Subcutaneous Insulin Infusion System in Adult Participants With Type 1 Diabetes	Phase 3
Completed	`NCT04587297` - Food Collection From Type 1 Diabetic Patients Practicing Insulin Functional Therapy